Sign in
Taking people in United StatesNo phase

Digital health coaching and activity tracker for people with relapsed multiple myeloma

Tests a phone-based health coaching program in adults with relapsed multiple myeloma.

Key facts

Who runs it
Pack Health
Where
Seattle, United StatesSee the site
Trial code
Registry title
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Status
Recruiting
People taking part
100 people, planned
Started
15 Sept 2023
Planned end
31 Aug 2026
Type of study
Interventional
Treatments tested
  • Digital Health Coaching Program
  • Fitbit
Record updated
20 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults whose multiple myeloma has come back or stopped responding to treatment. It tests a 3-month digital health coaching program with a wrist-worn activity tracker.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Confirmed multiple myeloma, including people who also have AL amyloidosis. They must be starting at least their second line of myeloma treatment.
Earlier treatment
Must have had at least one proteasome inhibitor (PI) and/or one immunomodulatory drug (IMiD).

Main reasons for not taking part

  • Terminally ill: 6 months or less to live, or comfort measures only
  • Took part before in Pack Health digital health coaching
  • Not enough English, as judged by the doctor
  • No personal smartphone or device for text, email or mobile app
  • Joined another treatment study in relapsed/refractory myeloma that does not allow joining this one

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age 18 or older
  • Confirmed diagnosis of MM as determined by participants' primary physicians at the study site. Patients with concurrent AL amyloidosis will be eligible
  • Initiation of at least the second line of MM-directed therapy for multiple myeloma at time of study enrollment. Participants must have been exposed to at least one proteasome inhibitor (PI) and/or one immunomodulatory drug (IMiD)

Who cannot take part

  • Individuals who have previously participated in Pack Health digital health coaching
  • Concurrent enrollment on a therapeutic study in R/R MM that precludes simultaneous enrollment onto our non-therapeutic study
  • Any serious and/or unstable pre-existing medical, psychiatric, or other condition that could interfere with participant's safety, provision of informed consent, or compliance with study procedures
  • Individuals who are terminally ill, defined as individuals identified by their physician as likely having 6 months or less to live, or those individuals transitioned to comfort measures only (meaning only supportive care measures without curative focused treatment)
  • Physician-assessed lack of sufficient English proficiency
  • Lack of ownership of a personal smartphone or device allowing for access to text, email or mobile application

Where in United States

  • University of WashingtonSeattle, United StatesContact: Trenton GrossfeldTaking people

About the trial

What the trial wants to find out

This study will evaluate the feasibility of a digital health coaching program for adults with relapsed or refractory multiple myeloma (R/R MM). One hundred adults with R/R MM will be enrolled at The University of Washington. Individuals who agree to take part in the study and sign an informed consent will be enrolled in a 3-month digital health coaching program. The program will provide weekly phone calls plus the delivery of learning materials to text or email. Questionnaires and data from a wrist-worn activity tracker will be collected. Outcomes include treatment and symptom experience, quality of life, financial burden, and how confident people feel to manage their health. Information about your condition and treatment will be collected, along with how often you use services like the emergency room, for care. This data will provide a better understanding of how a person experiences their R/R MM.

The group in the trial

  • Single Arm Cohort Receiving Digital Health CoachingTreatment being tested

    All study participants will be enrolled in a 3-month digital health coaching program. They will also receive a Fitbit device to be worn daily for the capture of physical activity data.

    Treatment: Digital Health Coaching Program and Fitbit

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating Patient-Reported Outcomes and Wearable Data Among Individuals With Relapsed/Refractory Multiple Myeloma
Plain-language title
Digital health coaching and activity tracker for people with relapsed multiple myelomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
20 April 2025